{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T06:30:52Z","timestamp":1772951452394,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K18994"],"award-info":[{"award-number":["24K18994"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijcha.2025.101787","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T17:42:40Z","timestamp":1756489360000},"page":"101787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical utility of segmental native T1 mapping for diagnosis and risk-stratification in cardiac sarcoidosis"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2441-3593","authenticated-orcid":false,"given":"Hidehiro","family":"Iwakawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Kaimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2025.101787_b0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac Sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101787_b0010","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s12350-016-0658-1","article-title":"Isolated cardiac sarcoidosis: A focused review of an under-recognized entity","volume":"25","author":"Okada","year":"2018","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101787_b0015","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcha.2025.101787_b0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-8703(99)70115-8","article-title":"Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies","volume":"138","author":"Uemura","year":"1999","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcha.2025.101787_b0025","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis","volume":"45","author":"Smedema","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101787_b0030","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2025.101787_b0035","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.124.013239","article-title":"Magnetic resonance imaging in the assessment of the risk of sudden death in cardiac sarcoidosis: What is extensive or significant late gadolinium enhancement?","volume":"18","author":"P\u00f6yh\u00f6nen","year":"2025","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ijcha.2025.101787_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocmr.2024.101031","article-title":"Impact of late gadolinium enhancement image acquisition resolution on neural network based automatic scar segmentation","volume":"26","author":"Hoh","year":"2024","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ijcha.2025.101787_b0045","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.crad.2016.02.013","article-title":"Assessment of myocardial fibrosis with T1 mapping MRI","volume":"71","author":"Everett","year":"2016","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ijcha.2025.101787_b0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12410-024-09594-8","article-title":"Insights of inflammatory heart involvement in cardiac sarcoidosis\u2013A systemic review","volume":"17","author":"Treiber","year":"2024","journal-title":"Curr. Cardiovasc. Imaging Rep."},{"key":"10.1016\/j.ijcha.2025.101787_b0055","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/eurheartj\/ehad067","article-title":"Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis","volume":"44","author":"Lehtonen","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2025.101787_b0060","doi-asserted-by":"crossref","unstructured":"Terasaki F, Azuma A, Anzai T, et al.; Japanese Circulation Society Joint Working Group. JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis- Digest Version. Circ J. 2019;83:2329-2388.","DOI":"10.1253\/circj.CJ-19-0508"},{"key":"10.1016\/j.ijcha.2025.101787_b0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jcmg.2017.04.006","article-title":"Native T1 Mapping and Extracellular volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy","volume":"11","author":"Nakamori","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcha.2025.101787_b0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12968-023-00918-z","article-title":"Regional extracellular volume within late gadolinium enhancement-positive myocardium to differentiate cardiac sarcoidosis from myocarditis of other etiology: a cardiovascular magnetic resonance study","volume":"25","author":"Treiber","year":"2023","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ijcha.2025.101787_b0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12968-019-0520-0","article-title":"Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis","volume":"21","author":"Gr\u00e4ni","year":"2019","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ijcha.2025.101787_b0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12968-018-0443-1","article-title":"Noninvasive hematocrit assessment for cardiovascular magnetic resonance extracellular volume quantification using a point-of-care device and synthetic derivation","volume":"20","author":"Robison","year":"2018","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ijcha.2025.101787_b0085","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00259-011-1832-y","article-title":"18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis","volume":"38","author":"Ohira","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ijcha.2025.101787_b0090","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1532-429X-15-78","article-title":"Standardization of T1 measurements with MOLLI in differentiation between health and disease\u2013the ConSept study","volume":"15","author":"Rogers","year":"2013","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ijcha.2025.101787_b0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41824-021-00119-w","article-title":"Combined simultaneous FDG-PET\/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis","volume":"5","author":"Cheung","year":"2021","journal-title":"Eur J Hybrid Imaging."},{"issue":"9","key":"10.1016\/j.ijcha.2025.101787_b0100","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.jcmg.2020.04.017","article-title":"Multiparametric Mapping Approach for Detection of Cardiac Involvement in Systemic Sarcoidosis","volume":"13","author":"Nakamori","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcha.2025.101787_b0105","article-title":"Gadolinium-based Contrast Agents: Updates and answers to typical questions Regarding Gadolinium Use","volume":"49","author":"Cheong","year":"2022","journal-title":"Tex. Heart Inst. J."},{"key":"10.1016\/j.ijcha.2025.101787_b0110","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf051","article-title":"Outcomes of ventricular tachycardia ablation facilitated by pre-procedural cardiac imaging-derived scar characterization: a prospective multi-centre international registry","volume":"27","author":"Penela","year":"2025","journal-title":"Europace"},{"key":"10.1016\/j.ijcha.2025.101787_b0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ehjci\/jeu182","article-title":"Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis","volume":"16","author":"Iles","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcha.2025.101787_b0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcmg.2015.12.001","article-title":"International T1 multicentre CMR outcome study. T1-mapping and outcome in nonischemic cardiomyopathy: All-cause mortality and heart failure","volume":"9","author":"Puntmann","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcha.2025.101787_b0125","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCULATIONAHA.109.930636","article-title":"Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans","volume":"122","author":"Flett","year":"2010","journal-title":"Circulation"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725001903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725001903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T18:09:18Z","timestamp":1772906958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906725001903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":25,"alternative-id":["S2352906725001903"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101787","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utility of segmental native T1 mapping for diagnosis and risk-stratification in cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101787"}}